1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Chromosome Disorders: new trials by email Literature Review of Chromosome Disorders trials Research Report on Chromosome Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome Placebo, Guanfacine extended release (GXR) - Prader-Willi Syndrome | Phase 4 | Withdrawn | NYU Langone Health | 2019-12-01 | 2020-08-26 |
Abnormalities, Multiple (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Imprinting Disorders (1) · Intellectual Disability (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Obesity (1) · Overnutrition (1) · Overweight (1)
United States (1)
Deepan Singh, MD (1)